DNA Origami Nanostructures for Single-Cell Multi-gene Analysis without Single Cell Sorting
DNA Origami Nanostructures for Single-Cell Multi-gene Analysis without Single Cell Sorting
批准号:
9302285
负责人:
Joseph N Blattman
金额:
$18.79万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-22 至 2018-05-31
关键词:
AddressAdoptedAntibodiesAntigensB-LymphocytesBindingBiological ProcessBiotinCell SeparationCellsComplementary DNACoupledDNADevelopmental BiologyDisease ProgressionEngineeringEquilibriumEquipmentGenesGeometryHumanImmuneImmune responseImmune systemImmunologyIndividualLaboratoriesLigationLinkLymphocyteMaintenanceMalignant NeoplasmsMeasuresMessenger RNAMethodsModernizationModificationMolecularMolecular BiologyMusNanostructuresOutcomePopulationPopulation HeterogeneityProcessReactionResearch PersonnelReverse TranscriptionT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTechniquesTechnologyTestingTransfectionTransgenic OrganismsValidationVirusalpha-beta T-Cell Receptorcancer cellcombatcostdeep sequencingdesigndisorder controlhigh standardimmunological diversityinternal controlmicrobial communitynext generation sequencingnovelnucleaseoncologypathogenprecursor cellresponsesequencing platformsingle cell analysissingle cell sequencingtumorvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Next generation sequencing platforms have revolutionized modern approaches for
understanding a wide variety of biological processes, including immune responses and cancer.
However, the diversity of the cells involved in these processes has important implications for
understanding biologic outcomes. For instance, the diversity of T cell receptors on lymphocytes
during responses to virus or cancer can have dramatic effects on disease progression.
Conversely, the diversity of cancer cells or virus populations has important implications for
successful control of disease. Therefore, a critical hurdle in these situations is the ability to
provide single-cell analysis techniques coupled with high-throughput next generation
sequencing, to adequately measure the diversity of cells. Unfortunately, current single-cell
analysis approaches are either unfeasible for large cell populations, too expensive, and/or
require specialized equipment that is not available to most labs. To address this problem, we
have engineered DNA origami nanostructures that are able to specifically bind and protect two
different mRNA within transfected cells, and use novel molecular approaches facilitated by the
constrained geometry of the mRNA bound to DNA origami to generate bi-cistronic amplicons for
use in paired-end high-throughput next generation sequencing. Importantly, the mRNA from
individual cells remain physically linked throughout this process, so linked sequences are from
individual cells. In this proposal we develop this approach for quantitating the diversity of
clonally-distributed TCRα and TCRβ T cell receptors in lymphocyte populations. We have
shown that we can transfect polyclonal populations of T cells with high efficiency, isolate DNA
origami nanostructures with bound TCR mRNA from transfected T cells, and generate CDR3
amplicons for Illumina 2x250 paired-end deep sequencing reactions to obtain linked TCRα and
TCRβ sequence information from individual T cells without the need for single cell sorting. We
propose to validate and use the developed DNA origami nanostructures to provide the first
estimate of total TCR diversity in the naïve T cell repertoires of mice. This technology will be
useful for downstream application to a wide variety of biologic processes, by relatively simple
modifications to the DNA origami nanostructure probe sequences, including single-cell analysis
of other diverse lymphocyte populations, including other T cell subsets or antibody producing B
cells, as well as single cells analysis of heterogeneous tumors or diverse microbial communities.
Moreover, because this approach utilizes equipment found in most modern molecular biology
laboratories, it can be easily adopted by many researchers for these analyses.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Enhancing CD8 T Cell Function by Abrogating Inhibition by Regulatory Proteins
-
批准号:7858197
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2006
-
负责人:Joseph N Blattman
-
依托单位:
Enhancing CD8 T Cell Function by Abrogating Inhibition by Regulatory Proteins
-
批准号:7014692
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2006
-
负责人:Joseph N Blattman
-
依托单位:
Enhancing CD8 T Cell Function by Abrogating Inhibition by Regulatory Proteins
-
批准号:7252584
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2006
-
负责人:Joseph N Blattman
-
依托单位:
Enhancing CD8 T Cell Function by Abrogating Inhibition by Regulatory Proteins
-
批准号:7467954
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2006
-
负责人:Joseph N Blattman
-
依托单位:
Enhancing CD8 T Cell Function by Abrogating Inhibition by Regulatory Proteins
-
批准号:7642451
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2006
-
负责人:Joseph N Blattman
-
依托单位:
海外基金